A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritis (Q33991896)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritis |
scientific article |
Statements
1 reference
A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritis (English)
1 reference
Daniel E Furst
1 reference
Roy Fleischmann
1 reference
Elliott Kopp
1 reference
Michael Schiff
1 reference
Carl Edwards
1 reference
Alan Solinger
1 reference
Michael Macri
1 reference
990136 Study Group
1 reference
1 December 2005
1 reference
1 reference